Trial reportJournal of asthma and allergy2026
Effect of Chewing Gum on Fractional Exhaled Nitric Oxide Values in Patients with Asthma: A Proof of Concept Study.
Trial report in Journal of asthma and allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Fractional exhaled nitric oxide (FeNO) is an important biomarker that is used to phenotype patients with (severe) asthma. This study evaluated the effect of chewing gum on FeNO values. Patients and Methods: Patients with stable asthma and elevated FeNO (≥25 ppb) were randomised to the control group (no chewing gum) or to chew gum for 15 minutes after a baseline FeNO measurement. A second FeNO measurement was performed 15 minutes after the first. The primary endpoint was the change in FeNO from baseline to 15 minutes. Results: Thirty patients with asthma (15 male, age 52±15 years) were randomised to the control or chewing gum group. Clinical characteristics, medications, laboratory testing and pulmonary function did not differ significantly between the two groups. The change in FeNO from baseline to 15 minutes was -3.3 ppb in the chewing gum group (p=0.02 vs. baseline) and +3.2 ppb in the control group (p=0.003 vs. baseline); the between-group difference for this change (median -13% in the chewing gum group vs. median +7% in the control group) was statistically significant (p=0.001). Conclusion: The present study showed for the first time that chewing gum influences FeNO measurement in patients with asthma. This is clinically relevant because FeNO is an important biomarker for the diagnosis, phenotyping and antibody-based treatment of asthma. Based on our findings, patients should be advised not to chew gum before the measurement of FeNO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.